LH

Laboratory Corporation of America Holdings
NYSEHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$22.80B
P/E Ratio
24.61
EPS
$11.30
Beta
0.86
52W High
$291.40
52W Low
$239.28
50-Day MA
$262.44
200-Day MA
$267.36
Dividend Yield
1.01%
Profit Margin
6.66%
Forward P/E
15.87
PEG Ratio
1.20

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$14.14B
Gross Profit (TTM)$4.08B
EBITDA$2.25B
Operating Margin11.00%
Return on Equity11.10%
Return on Assets5.31%
Revenue/Share (TTM)$170.67
Book Value$106.06
Price-to-Book2.67
Price-to-Sales (TTM)1.61
EV/Revenue2.091
EV/EBITDA14.34
Quarterly Earnings Growth (YoY)32.90%
Quarterly Revenue Growth (YoY)5.80%
Shares Outstanding$82.00M
Float$81.60M
% Insiders0.35%
% Institutions101.01%

Historical Volatility

HV 10-Day
25.06%
HV 20-Day
25.65%
HV 30-Day
22.84%
HV 60-Day
21.06%
HV Rank
52.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($311.00 target)
2
Strong Buy
12
Buy
5
Hold

Latest News

LH or CRL: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research7/1/2026Positive
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas Designed to reduce common barriers to at-home screening with a cleaner, simplified collection experience that minimizes sample handling Meets screening guidelines from the American Cancer Society (ACS) and National Comprehensive Cancer Network (NCCN) BURLINGTON, N.C. and ST. LOUIS, June 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal cancer (CRC) screening approved by the U.S. Food and Drug Administration (FDA).

PRNewsWire6/22/2026Neutral
LH vs. CRL: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Charles River Laboratories (CRL). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research6/15/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026